Bright Minds Biosciences Inc (DRUG)
Operating Cash Flow (Statement)
-$8.42M
Quarterly · Period ending: · CAD
DRUG Operating Cash Flow (Statement)
Latest reported-$8.42M CADperiod ending
Latest reported-$8.42M CADperiod ending
DRUG Quarterly Cash from Operations · CAD (-$59.73K → -$8.42M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DRUG operating cash flow (statement) history
Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (CAD) |
|---|---|
| -8,418,630 | |
| -9,496,251 | |
| -5,815,901 | |
| -1,268,008 | |
| -3,503,935 | |
| -2,425,282 | |
| -1,494,394 | |
| -463,170 | |
| 240,160 | |
| -805,089 | |
| -822,087 | |
| -1,197,524 | |
| -1,650,548 | |
| -1,512,521 | |
| -2,663,672 | |
| -2,128,594 | |
| -2,862,076 | |
| -3,645,475 | |
| -4,950,971 | |
| -2,389,569 | |
| -2,972,749 | |
| -1,407,465 | |
| -549,518 | |
| -210,631 | |
| 19,795 | |
| -37,823 | |
| -59,733 |